Literature DB >> 26636393

Renal Function and Urinary Biomarkers in Cardiac Bypass Surgery: A Prospective Randomized Trial Comparing Three Surgical Techniques.

Stefanie Deininger1, Markus Hoenicka1, Kristina Müller-Eising1, Patricia Rupp1, Andreas Liebold1, Wolfgang Koenig2, Hagen Gorki1.   

Abstract

Background Cardiopulmonary bypass procedure is associated with an increased risk of renal impairment. To which extent structural damage causes functional decline is unknown. We evaluated perioperative kidney injury and function in patients treated with conventional extracorporeal circulation (CECC), minimized extracorporeal circulation (MECC), and off-pump coronary artery bypass grafting (OPCAB). Methods Blood and urine samples, collected at baseline and up to 72 hours after surgery from patients of the HEPCON trial (DRKS00007580, 120 patients randomized for heparin management and for surgical technique), were analyzed for differences in renal injury and function. Neutrophil gelatinase-associated lipocalin, α glutathione S-transferase, liver fatty acid-binding protein, and kidney injury molecule-1 were measured as urinary protein markers of renal tubular injury. Serum creatinine, blood urea levels, and estimated glomerular filtration rate were determined to monitor renal function. Results Markers of tubular injury differed significantly between surgical technique groups early after surgery, indicating the most detrimental effect in CECC. Hemolysis and hemodilution correlated with these early changes. A late rise did not show intergroup differences. Time courses of renal function parameters, as well as the development of acute kidney injury in 15 patients (13.5%), were irrespective of surgical technique. Heparin management did not influence renal parameters. Conclusion During coronary artery bypass grafting, CECC temporarily induces more tubular injury than MECC or OPCAB. However, late changes of renal function parameters occur irrespective of extracorporeal perfusion mode and even in off-pump surgery. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26636393     DOI: 10.1055/s-0035-1567871

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

Review 1.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

2.  Effects of pulsatile minimal invasive extracorporeal circulation on fibrinolysis and organ protection in adult cardiac surgery-a prospective randomized trial.

Authors:  Angelika Graßler; Robert Bauernschmitt; Irene Guthoff; Andreas Kunert; Markus Hoenicka; Günter Albrecht; Andreas Liebold
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

3.  Initial experiences with a centrifugal-pump based minimal invasive extracorporeal circulation system in pediatric congenital cardiac surgery.

Authors:  Alexander Kadner; Paul Philipp Heinisch; Maris Bartkevics; Serena Wyss; Hans-Joerg Jenni; Gabor Erdoes; Balthasar Eberle; Thierry Carrel
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

4.  Conventional versus miniaturized cardiopulmonary bypass: A systematic review and meta-analysis.

Authors:  Timothy Cheng; Rajas Barve; Yeu Wah Michael Cheng; Andrew Ravendren; Amna Ahmed; Steven Toh; Christopher J Goulden; Amer Harky
Journal:  JTCVS Open       Date:  2021-10-01

5.  Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery.

Authors:  Chong Lei; Lorenzo Berra; Emanuele Rezoagli; Binglan Yu; Hailong Dong; Shiqiang Yu; Lihong Hou; Min Chen; Wensheng Chen; Hongbing Wang; Qijun Zheng; Jie Shen; Zhenxiao Jin; Tao Chen; Rong Zhao; Emily Christie; Venkata S Sabbisetti; Francesco Nordio; Joseph V Bonventre; Lize Xiong; Warren M Zapol
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 30.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.